This review of newer treatments reflects our understanding of the complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and precise molecular targeting. https://t.co/SBsJ6KFF6h
Time to focus on the real potential benefit of endobiliary radiofrequency ablation: stent patency in patients with cholangiocarcinoma https://t.co/VNkcjlqe6i
Response to: Correspondence on 'Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion by Wang et al https://t.co/28enuAWVhK
Endoscopic mucosal resection for large non-pedunculated colorectal polyps: staying on track with a safe, effective and cost-efficient technique https://t.co/7yWn4gX2o5
Efficacy of dupilumab in patients with prior exposure to topical steroids: facing second-line treatments for eosinophilic oesophagitis https://t.co/4KaBLeAErJ
Dominant-negative effect of lactase missense variants: hetero-complex assembly with the wild-type enzyme impairs intracellular trafficking and digestive function https://t.co/wSaIF1gLNb
Thermal ablation of the resection base after endoscopic mucosal resection: a useful tool when perfect technique is not achievable https://t.co/e9iUeZ72Nl
[Articles] Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial https://t.co/amzXwp0uqu